CDKN2A and neoplasm: It was initially recognized as a critical intrinsic defense mechanism that suppresses tumorigenesis, primarily induced by key tumor-suppressive pathways such as those governed by p53 (the guardian of the genome) and the p16/Rb (retinoblastoma protein) pathway [3].